XML 48 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated statements of profit or loss - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
 [1]
Profit or loss [abstract]      
Revenue € 386,962 € 428,539 € 448,880
Cost of sales (271,931) (308,250) (318,401)
Gross Profit 115,031 120,289 130,479
Other income 5,162 5,944 1,650
Selling expenses (105,250) (114,997) (118,254)
Administrative expenses (34,026) (35,344) (36,105)
Impairment on trade receivables (2,389) (745) (1,475)
Other expenses (1,016) (605) (250)
Operating loss (22,488) (25,458) (23,955)
Finance income 400 379 1,252
Finance costs (7,928) (5,580) (6,289)
Net exchange rate gains/(losses) (2,340) (3,914) 1,033
Gain from disposal and loss of control of a subsidiary   75,411  
Net finance income/(costs) (9,868) 66,296 (4,004)
Share of profit/(loss) of equity-method investees 1,011 (290)  
Profit/(loss) before tax (31,345) 40,548 (27,959)
Income tax expense (2,335) (7,429) (2,886)
Profit/(loss) for the year (33,680) 33,119 (30,845)
Profit/(loss) attributable to:      
Owners of the Company (33,370) 33,289 (30,392)
Non-controlling interests € (310) € (170) € (453)
Profit/(loss) per share      
Basic profit/(loss) per share € (0.61) € 0.61 € (0.55)
Diluted profit/(loss) per share € (0.61) € 0.61 € (0.55)
[1] The Group has initially applied IFRS 9 as at January 1, 2018. Under the transition method chosen, comparative information has not been restated except for separately presenting impairment losses on trade receivables. See note 5(c).